Clinical Trial Update: Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2 [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase II trial evaluating a multichannel auditory brain stem implant for deafness in patients who had surgery for Neur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type 2
• Sensorineural Deafness

Drugs mentioned

• Multichannel Auditory Brain Stem Implant

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Neurofibromatosis 2 | Phase 2 | Status: COMPLETED